Sundar PichaiSundar Pichai earned $164M in 2023

Fred P. Lampropoulos has been leading Merit Medical Systems since December 2015 as both the CEO and President. Under his leadership, the company has not only focused on critical areas like strategic business development and product innovation but has also...

Quick Links
M

Fred P. Lampropoulos

Founder and CEO of Merit Medical Systems

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of Merit Medical Systems for

9 years 4 months (Dec 2015 - Present)

Previous Experience

President of Merit Medical Systems Inc.

Holdings

See how much did Fred P. Lampropoulos make over time.

Fred P. Lampropoulos has significant holdings in Merit Medical Systems inc, which are reflective of the company's growth trajectory. In 2023, he received stock options and other equity awards valued at approximately $2.77 million, which aligns with his $10 million...

Loading...

Total Stock Sold

$11.19M

MMSI

$11.19M

328,250 MMSI shares

What if they kept their stock?

If Fred P. Lampropoulos didn't sell their stock, today they would have:
Extra MMSI328,250 shares worth $10.99M.
This is -1.73% and $193.62K less than what they got when they sold the stock.

Charitable Transactions

MMSI

11,817 shares

MMSI

Recent Charitable Transactions

MMSI

11,817 shares

MMSI

Mar 6, 2015

Charity

Insider Trading

See recent insider trades of Fred P. Lampropoulos.

MMSI

$3.56M

MMSI at $103.83/share

Mar 5, 2025

Sale

MMSI

51,139 shares

MMSI

Feb 27, 2025

Received

MMSI

43,534 shares

MMSI

Mar 4, 2024

Received

MMSI

$1.70M

MMSI at $68.04/share

Mar 14, 2023

Sale

MMSI

$1.45M

MMSI at $70.02/share

Feb 28, 2023

Sale

MMSI

27,159 shares

MMSI

Feb 28, 2023

Received

MMSI

17,680 shares

MMSI

Feb 26, 2022

Received

MMSI

$294.84K

MMSI at $59.60/share

Mar 12, 2021

Sale

MMSI

8,840 shares

MMSI

Feb 26, 2021

Received

MMSI

$220.00K

MMSI at $44.00/share

May 20, 2020

Sale

Compensation History

See how much did Fred P. Lampropoulos make over time.

In 2023, Fred P. Lampropoulos earned a total compensation of $10,052,664, including a base salary of $1,890,000, a bonus based on company performance, and stock awards valued at approximately $2.77 million. His compensation has notably increased over the years, showing a steady growth in line with the company's upward trajectory. In contrast, in 2019, Lampropoulos' total compensation was only $2,045,664. The structure of his pay emphasizes aligning him with the company’s financial success. Performance metrics used to decide his bonuses include total shareholder return, net sales, and earnings per share, which keeps him focused on fostering growth and value for shareholders.

Year

2023

Total Compensation

$6.01M

Salary

$1.89M

Board Justification

The compensation philosophy is to align the interests of management and shareholders for the purpose of maximizing shareholder value, while considering the interests of other significant stakeholders such as employees, patients, customers, business partners and the communities in which we operate.

Bonus

$1.34M

Board Justification

Based on the Company’s achievement of goals established by the Compensation Committee, the Compensation Committee determined to award and pay the annual cash bonus at 118.12% of the target payment amount for 2023.

Other

$8.70K

Board Justification

Includes matching contributions made by the Company for the benefit of Mr. Lampropoulos to the Company’s 401(k) Plan.

Restricted Stock

$2.77M(18.96K RSU)

Board Justification

Represents the number of shares of stock that vested in 2023 under the performance stock units (PSUs) granted in prior years, based on the achievement of performance metrics.

Performance Metrics

The performance metrics for determining the compensation of the CEO include total shareholder return, net sales, non-GAAP operating margin, non-GAAP earnings per share, and adjusted free cash flow.